December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th & 12th, 2024

DIGITAL MEETINGS

Thom Frielink

Thom Frielink

Associate
The NetherlandsCurie Capital

Thom is Associate at Curie Capital, involved with dealflow and portfolio management. Prior to his role at Curie Capital, he has gained 7 years of consultancy experience in raising funding for biopharmaceutical and medtech companies. In these functions Thom was involved in raising over €85 million non-dilutive capital and has developed in-depth knowledge on a wide range of topics in Life Sciences. In addition, he was the CEO of 2ndB, an Organ-on-Chip start-up. Thom has a BSc and MSc in Science and Innovation Management at Utrecht University, as well as an executive MBA from the Vlerick Business School.